Company History

Mayne Pharma Pills in capsule


Salisbury site acquired in 1983 by F H Faulding & Co Limited.
Development of delayed-release doxycycline capsules (DORYX®).
Development of enteric coated aspirin (ASTRIX®).
WF Scammell Research Centre opened at Salisbury.


Development of taste-masking technology (CLEANTASTE®).
Development of sustained-release morphine (KADIAN® / KAPANOL®).
Metrics founded as a contract testing company in Greenville, North Carolina.


Development of improved bioavailability technology (SUBA™).
Development of pellet-in-a-tablet technology (DORYX®).
Development of LOZANOC®/TOLSURA® improved formulation of itraconazole.
Mayne Pharma LAB


Mayne Pharma acquires Metrics, Inc. – CDMO with niche generic product portfolio and pipeline.
Acquired DORYX® brand and related assets in the US from Actavis.
Mayne Pharma acquires US portfolio of products from Teva and Allergan in the US.
Mayne Pharma acquires US foam dermatology products from GSK – FABIOR® and SORILUX®.
New solid oral dose manufacturing facility in Greenville, NC, USA opened.